Viral Hepatitis Prevention and Control

 

Program activities under this funding will allow for CDC to partner with multiple organizations to benefit individuals by substantially reducing viral hepatitis transmission, identifying those that are acutely and chronically infected, and linking infected individuals with treatment if appropriate. Specifically, the program activities may include but are not limited to: 1. Increasing the proportion of persons living with HCV and HBV who are aware of their infection and referred for prevention and clinical care services. 2. Expanding and improving efforts to develop and disseminate viral hepatitis training and educational materials targeting the public and private sector health care professionals to build capacity to assess, test and medically manage populations at risk for chronic HCV and HBV infection. 3. Supporting state and local health departments and other organizations in linking HCV infected persons to community health centers, clinics serving injection drug users, and other health organizations seeing individuals potentially infected with chronic viral hepatitis. 4. Increase the number of reported incidence cases being reported in state and local health departments. 5. Additional support will be provided for program monitoring, evaluation, capacity building, and technical assistance, along with support for acute and chronic viral hepatitis surveillance.

General information about this opportunity
Last Known Status
Active
Program Number
93.270
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Fiscal Year 2016 Funding will continue to be provided for hepatitis B and C testing and linkage to care activities, and to characterize the hepatitis C increase among injection drug users as well as continued support for viral hepatitis surveillance, prevention and education. Funds were provided for hepatitis B and C testing and linkage to care activities, and to characterize the hepatitis C increase among injection drug users as well as continued support for viral hepatitis surveillance, prevention and education
Fiscal Year 2017 Funding was provided to state and local health departments to increase testing and linkage to care if necessary for chronically infected individuals with viral hepatitis B and C.
Fiscal Year 2018 Funding is provided to state and local health departments to increase testing and linkage to care if necessary for chronically infected individuals with viral hepatitis B and C.
Fiscal Year 2019 Funding will continue to be provided to state and local health departments to increase testing and linkage to care if necessary for chronically infected individuals with viral hepatitis B and C.
Authorization
Sections 301 and 317K(k)(2) of the Public Health Service Act (42 U.S.C. section 241 and 274b-15), as amended
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Applicants include State or local governments or their Bona Fide Agents, public and private nonprofit organizations, for profit organizations, small, minority, women-owned businesses, universities, colleges, research institutions, hospitals, community-based organizations, faith based organizations, Federally recognized Indian tribal governments, Indian tribes, and Indian tribal organizations. Additional guidance may be provided in individual program announcements. In addition, funds may be used for costs associated with establishing and maintaining a prevention and control program directed towards prevention of viral hepatitis infections and their manifestations. Recipients may only expend funds for reasonable policies, systems and program purposes including personnel, travel, supplies and services, such as reducing transmission of HAV, HBV and HCV, preventing and delaying the progress of chronic infection, as well as educating and training of the general public and health care providers. Recipients may not use funds for clinical care. Recipients may not generally use funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award in another party or provider who is eligible.
Beneficiary Eligibility
The individual will benefit from the objectives of this program as well as the community at large, and society from the savings realized from treating those who are infected with viral hepatitis. .
Credentials/Documentation
Not applicable.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, contact the CDC Office of Grant Services Technical Information Management Section (OGS-TIMS) staff. For this, or further assistance, contact OGS-TIMS: Telephone (770) 488-2700, Email: ogstims@cdc.gov.
Award Procedure
Successful applicants will receive a Notice of Award (NoA) from the CDC Office of Grants Services. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and emailed to the program director, and a hard copy mailed to the recipient fiscal officer identified in the application.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 120 to 180 days. Deadline for submission of applications will be between 30-60 days from date of publication.
Appeals
Not applicable.
Renewals
Not applicable.
How are proposals selected?
The critieria for selection is posted in the NOFO and an objective review is held with each applicant scored and ranked based on score and funding preferences which are listed in the NOFO as well. Prior to objective review, applications will be reviewed for completeness by Office of Grants Services (OGS) staff and for responsiveness jointly by Division of Viral Hepatitis (DVH), NCHHSTP. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicant will be notified that the application did not meet submission requirements.
How may assistance be used?
Funds may be used for costs associated with establishing and maintaining a prevention and control program directed towards prevention of viral hepatitis infections and their manifestations. Recipients may only expend funds for reasonable policies, systems and program purposes including personnel, travel, supplies and services, such as reducing transmission of HAV, HBV and HCV, preventing and delaying the progress of chronic infection, as well as educating and training of the general public and health care providers. Recipients may not use funds for clinical care. Recipients may not generally use funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award in another party or provider who is eligible.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Performance Reports are required as part of the progress report, and rapid feedback reports are part of the process for monitoring.
Auditing
Not applicable.
Records
Financial records, supporting documents, statistical records, and all other reports pertinent to the program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Project period is for 2-5 years with 12-month budget periods. Assistance is awarded through Notice of Grant Awards (NoAs) to funded applicants. Award through a Notice of Grant Award (NoA).
Who do I contact about this opportunity?
Regional or Local Office
Viral Hepatitis Program Contact: Jeffrey L. Efird, MPA, Deputy Director, Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Rd. NE, Mailstop G-37, Atlanta, GA 30333. E-mail: jle1@cdc.gov.
Headquarters Office
Jeff Efird, MPA, Deputy Director, Division of Viral Hepatitis
1600 Clifton Road, NE, Mailstop G-37
Atlanta, GA 30333 US
jle1@cdc.gov
Phone: (404) 718-8504

Lisa Williams
1600 Clifton Road NE, MS E-07
Atlanta, GA 30333 USA
LRW3@cdc.gov
Phone: (404)639-1877
Website Address
http://www.cdc.gov/
Financial Information
Account Identification
09-2950-2-0-131
Obligations
(Cooperative Agreements) FY 18$19,979,265.00; FY 19 est $19,979,265.00; FY 20 FY 17$17,034,281.00; FY 16$16,815,000.00; - Funding is provided to state and local health departments to increase testing and linkage to care if necessary for chronically infected individuals with viral hepatitis B and C.(Cooperative Agreements) FY 18$19,685,215.00; FY 19 est $21,794,750.00; FY 20 est $22,500,000.00; -
Range and Average of Financial Assistance
Awards will range from approximately $30,000 to $500,000, with an average award of $150,000.
Regulations, Guidelines and Literature
Not applicable.
Examples of Funded Projects
Fiscal Year 2016 CDC's Division of Viral Hepatitis continued funding 54 grantees to conduct hepatitis prevention and surveillance activities as well as a several educational projects and projects that identify and screen chronically infected hepatitis B and C patients and link them to care. CDC's Division of Viral Hepatitis supported funding 54 grantees to conduct hepatitis prevention and surveillance activities as well as a several educational projects and projects that identify and screen chronically infected hepatitis B and C patients and link them to care.